Toronto Dominion Bank
RLAY icon

Toronto Dominion Bank’s Relay Therapeutics RLAY Stock Holding History

Toronto Dominion Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8K Buy
+900
New +$13.1K ﹤0.01% 2041
2022
Q1 		– Sell
-55,643
Closed -$1.71M – 1886
2021
Q4 		$1.71M Buy
+55,643
New +$1.76M ﹤0.01% 881

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Toronto Dominion Bank's RLAY Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 900 shares worth $16.8K. The stake represents ﹤0.01% of the portfolio and ranks #2041 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in RLAY as recently as Q4 2021.

Toronto Dominion Bank first reported a position in RLAY in Q4 2021 and has held it in 2 quarters since. The position peaked at $1.71M in Q4 2021. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Toronto Dominion Bank held 900 shares of Relay Therapeutics worth $16.8K as of Q2 2026.
  • Relay Therapeutics was a new Toronto Dominion Bank position in Q2 2026.
  • Relay Therapeutics made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #2041 holding.
  • Toronto Dominion Bank first reported a position in Relay Therapeutics in Q4 2021 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Relay Therapeutics position peaked at $1.71M in Q4 2021.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.